-
1دورية أكاديمية
المؤلفون: Mateos Manteca, María Victoria, Hernández, José M., Hernández, Miguel T., Gutiérrez Gutiérrez, Norma Carmen, Palomera, Luis, Fuertes, M., Díaz-Mediavilla, Joaquín, Lahuerta, Juan José, De la Rubia, Javier, Terol, María-José, Sureda, Anna, Bargay, Joan, Ribas, Paz, De Arriba, Felipe, Alegre, Adrian, Oriol, Albert, Carrera, Dolores, García-Laraña, José, García Sanz, Ramón, Bladé, Joan, Prósper, Felipe, Mateo, Gemma, Esseltine, Dixie-Lee, van de Velde, Helgi, San Miguel Izquierdo, Jesús Fernando
مصطلحات موضوعية: Mieloma múltiple, Disease-Free Survival, Immunophenotyping, Aged, Boronic Acids, Humans, Pyrazines, Melphalan, Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Agents, Multiple Myeloma, Maximum Tolerated Dose, Cohort Studies, Prednisone, protocolos de quimioterapia antineoplásica combinada, humanos, anciano, supervivencia sin enfermedad, prednisona, inmunofenotipificación, ácidos borónicos, dosis máxima tolerada, estudios de cohortes, antineoplásicos, piracinas, melfalán
العلاقة: https://doi.org/10.1182/blood-2006-04-019778Test; Mateos, M. V., Hernández, J. M., Hernández, M. T., Gutiérrez, N. C., Palomera, L., Fuertes, M., . & Miguel, J. F. S. (2006). Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study. Blood, 108(7), 2165-2172. https://doi.org/10.1182/blood-2006-04-019778Test; http://hdl.handle.net/10366/154234Test
-
2دورية أكاديمية
المؤلفون: Lonial, Sagar, Weiss, Brendan M, Usmani, Saad Z, Singhal, Seema, Chari, Ajai, Bahlis, Nizar J, Belch, Andrew, Krishnan, Amrita, Vescio, Robert A, Mateos, Maria Victoria, Mazumder, Amitabha, Orlowski, Robert Z, Sutherland, Heather J, Bladé, Joan, Scott, Emma C, Oriol, Albert, Berdeja, Jesus, Gharibo, Mecide, Stevens, Don A, Leblanc, Richard, Sebag, Michael, Callander, Natalie, Jakubowiak, Andrzej, White, Darrell, De La Rubia, Javier, Richardson, Paul G., Lisby, Steen, Feng, Huaibao, Uhlar, Clarissa M, Khan, Imran, Ahmadi, Tahamtan, Voorhees, Peter M
المصدر: The Lancet, 387(10027)
مصطلحات موضوعية: Kaplan-Meier Estimate, Male, Antineoplastic Agents, Antibodies, Monoclonal, Spain, Middle Aged, Disease-Free Survival, United States, Antineoplastic Combined Chemotherapy Protocols, daratumumab, Female, Drug Administration Schedule, Aged, Drug Resistance, Neoplasm, Neoplasm Recurrence, Local, Multiple Myeloma, Canada, Treatment Outcome, Humans, Adult
العلاقة: https://doi.org/10.17615/c9e2-m654Test; https://cdr.lib.unc.edu/downloads/xs55mj293?file=thumbnailTest; https://cdr.lib.unc.edu/downloads/xs55mj293Test
الإتاحة: https://doi.org/10.17615/c9e2-m654Test
https://cdr.lib.unc.edu/downloads/xs55mj293?file=thumbnailTest
https://cdr.lib.unc.edu/downloads/xs55mj293Test